Antibodies

Items 91-100 of 156

per page
Set Descending Direction
  1. anti-Lipocalin-2 (rat), pAb
    AG-25A-0088
    AG-25A-0088-C100100 µg
    CHF 190.00
    Western blot analysis using anti-Lipocalin-2 (rat), pAb (Prod. No. AG-25A-0088) at 1:4'000 dilution.
1: Rat Lipocalin-2 (FLAG®-tagged).
2: Mouse Lipocalin-2 (FLAG®-tagged).
3: Human Lipocalin-2 (FLAG®-tag
  2. anti-LYVE-1 (mouse), pAb
    AG-25T-0102
    AG-25T-0102-C100100 µg
    CHF 320.00
    anti-LYVE-1 (mouse), pAb
  3. anti-LYVE-1, pAb
    AG-25T-0103
    AG-25T-0103-C05050 µg
    CHF 345.00
  4. anti-MDA5 (mouse), pAb (AL180)
    AG-25B-0001V
    AG-25B-0001V-C100100 µg
    CHF 440.00
    Western blot analysis anti-MDA5 (mouse), pAb (AL180) (Prod. No. AG-25B-0001) detecting the cleavage of endogenous mouse MDA5 as an indicator of apoptosis. Method: Cleavage of endogenous Helicard in murine A20 B lymphomas undergoing Fas-mediated apo
  5. anti-MerTK (mouse), Rabbit Monoclonal (RM469)
    REV-31-1361-00
    REV-31-1361-00-R100100 µl
    CHF 459.00
    anti-MerTK (mouse), Rabbit Monoclonal (RM469)
  6. anti-MPC-2, mAb (JCM-1)
    AG-20B-0071
    AG-20B-0071-C100100 µg
    CHF 540.00
  7. anti-NAIP1/2/5 (mouse), mAb (Naipa-1)
    AG-20B-0045
    AG-20B-0045-C100100 µg
    CHF 480.00
    /
  8. anti-Nampt (Visfatin/PBEF) (mouse), pAb
    AG-25A-0028
    AG-25A-0028-C100100 µg
    CHF 190.00
    Western blot analysis using anti-Nampt (mouse), pAb (Prod. No. AG-25A-0028) at 1:2'000 dilution.
1: Mouse Nampt (His-tagged).
  9. anti-Nampt (Visfatin/PBEF), mAb (OMNI379)
    AG-20A-0034
    AG-20A-0034-C05050 µg
    CHF 290.00
    AG-20A-0034-C100100 µg
    CHF 410.00
    Immunoprecipitation of recombinant human Nampt(Visfatin/PBEF) proteins using anti-Nampt (Visfatin-PBEF), mAb (OMNI379) (Prod. No. AG-20A-0034). Recombinant human Nampt(Visfatin/PBEF) proteins at different concentrations were precipitated. The precipitated

Items 91-100 of 156

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.